Status:
COMPLETED
Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population
Lead Sponsor:
The Cleveland Clinic
Conditions:
Kidney Transplant
Eligibility:
All Genders
Brief Summary
This is an observational multi-center study to determine whether any single immune monitoring test or a combination of tests obtained in the first 6 months after renal transplantation correlates with ...
Eligibility Criteria
Inclusion
- human kidney transplant recipients
- ATG or basiliximab induction therapy
Exclusion
- induction therapy other than ATG or basiliximab
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01914354
Start Date
February 1 2012
End Date
June 1 2014
Last Update
October 28 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.